FDA Inspection
Eurofins Donor & Product Testing Inc DallasEurofins Donor & Product Testing Inc Dallas – FDA Inspection, Nov 25, 2019
Record Details
This FDA Inspection record concerns Eurofins Donor & Product Testing Inc Dallas, with an inspection on November 25, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- November 25, 2019
- Product Type
- Biologics
View Company Profile
ID · 150ad2e1-4e2e-4215-83dd-ff719934165a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1110955
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.160(b)(6)Deviations--evaluation, cause, corrective action
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Eurofins Donor & Product Testing Inc Dallas
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 5, 2024 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 9, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Eurofins Donor & Product Testing Inc Dallas
- FDA Inspection 1231969 - 2024-03-05
- FDA Inspection 1024232 - 2017-08-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.